{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:47:20Z","timestamp":1790660840994,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005277","name":"PHS","doi-asserted-by":"publisher","award":["UL1TR000454"],"award-info":[{"award-number":["UL1TR000454"]}],"id":[{"id":"10.13039\/100005277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08-HL-119592"],"award-info":[{"award-number":["K08-HL-119592"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Society for Vascular Surgery\/American College of Surgeons Scientific Development","award":["IRG14740001"],"award-info":[{"award-number":["IRG14740001"]}]},{"name":"Emory Department of Surgery"}],"content-domain":{"domain":["jvascsurg.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jvs.2015.02.061","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T01:12:07Z","timestamp":1456362727000},"page":"826-838.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia"],"prefix":"10.1016","volume":"65","clinical-trial-number":[{"clinical-trial-number":"nct01659762","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Luke","family":"Brewster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Peister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Copland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2015.02.061_bib1","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2015.02.061_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.gheart.2013.12.010","article-title":"Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010","volume":"9","author":"Sampson","year":"2014","journal-title":"Glob Heart"},{"key":"10.1016\/j.jvs.2015.02.061_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jamcollsurg.2011.07.011","article-title":"A\u00a0framework for the evaluation of \u201cvalue\u201d and cost-effectiveness in the management of critical limb ischemia","volume":"213","author":"Barshes","year":"2011","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jvs.2015.02.061_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jvs.2009.08.073","article-title":"Critical limb ischemia","volume":"51","author":"Varu","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2015.02.061_bib5","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (basil): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2015.02.061_bib6","first-page":"199","article-title":"Lower extremity amputations for ischemic disease","volume":"13","author":"Towne","year":"1979","journal-title":"Adv Surg"},{"key":"10.1016\/j.jvs.2015.02.061_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jvs.2010.08.060","article-title":"Treatment of peripheral arterial disease using stem and progenitor cell therapy","volume":"53","author":"Lawall","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2015.02.061_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jvs.2012.03.255","article-title":"Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia","volume":"56","author":"Powell","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2015.02.061_bib9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/labinvest.2010.86","article-title":"Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice","volume":"90","author":"Amin","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.jvs.2015.02.061_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/term.461","article-title":"Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats","volume":"6","author":"Wang","year":"2012","journal-title":"J\u00a0Tissue Eng Regen Med"},{"key":"10.1016\/j.jvs.2015.02.061_bib11","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/mt.2012.52","article-title":"Cellular therapy with ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RTORE-CLI trial","volume":"20","author":"Powell","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.jvs.2015.02.061_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/eurheartj\/ehr018","article-title":"Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges","volume":"32","author":"Tongers","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2015.02.061_bib13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1160\/TH09-10-0688","article-title":"Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal","volume":"103","author":"Lawall","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2015.02.061_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2015.02.061_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ymthe.2004.02.012","article-title":"Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy","volume":"9","author":"Spees","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.jvs.2015.02.061_bib16","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jcyt.2013.05.020","article-title":"Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in\u00a0vitro","volume":"15","author":"Griffiths","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jvs.2015.02.061_bib17","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the Poseidon randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2015.02.061_bib18","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/01.CIR.0000124476.32871.E3","article-title":"Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease","volume":"109","author":"Heeschen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2015.02.061_bib19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvs.2015.02.061_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cardiores.2005.02.006","article-title":"Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia","volume":"66","author":"Iwase","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jvs.2015.02.061_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3109\/14653249.2012.663483","article-title":"The influence of cardiovascular risk factors on bone\u00a0marrow mesenchymal stromal cell fitness","volume":"14","author":"Neef","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jvs.2015.02.061_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jcyt.2013.01.010","article-title":"Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy","volume":"15","author":"Reinders","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jvs.2015.02.061_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/00365513.2010.550310","article-title":"Comparison of mesenchymal stromal cells from young healthy donors and patients with severe chronic coronary artery disease","volume":"71","author":"Friis","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jvs.2015.02.061_bib24","first-page":"83","article-title":"Colony forming unit assays for MSCs","volume":"449","author":"Pochampally","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jvs.2015.02.061_bib25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jcp.22239","article-title":"Frnk overexpression limits the depth and frequency of vascular smooth muscle cell invasion in a three-dimensional fibrin matrix","volume":"225","author":"Brewster","year":"2010","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jvs.2015.02.061_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.biomaterials.2007.09.034","article-title":"Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen","volume":"29","author":"Brewster","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jvs.2015.02.061_bib27","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2003-09-3070","article-title":"Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential","volume":"103","author":"Peister","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jvs.2015.02.061_bib28","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/stem.118","article-title":"Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression","volume":"27","author":"Ren","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.jvs.2015.02.061_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s007740170061","article-title":"Stromal cell activity in bone marrow from the tibia and iliac crest of patients with rheumatoid arthritis","volume":"19","author":"Suzuki","year":"2001","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.jvs.2015.02.061_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jcp.21690","article-title":"Hypoxia or in situ normoxia: the stem cell paradigm","volume":"219","author":"Ivanovic","year":"2009","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jvs.2015.02.061_bib31","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1582-4934.2011.01258.x","article-title":"Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia","volume":"15","author":"Carreau","year":"2011","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jvs.2015.02.061_bib32","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1634\/stemcells.2007-1104","article-title":"Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells","volume":"26","author":"Rosova","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.jvs.2015.02.061_bib33","doi-asserted-by":"crossref","first-page":"C1562","DOI":"10.1152\/ajpcell.00221.2010","article-title":"Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells","volume":"299","author":"Chacko","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jvs.2015.02.061_bib34","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/mt.2014.161","article-title":"Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls","volume":"22","author":"Gremmels","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.jvs.2015.02.061_bib35","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1073\/pnas.0711402105","article-title":"High glucose induces adipogenic differentiation of muscle-derived stem cells","volume":"105","author":"Aguiari","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvs.2015.02.061_bib36","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/bmt.2011.196","article-title":"Angiogenic potential of BM MSCS derived from patients with critical leg ischemia","volume":"47","author":"Smadja","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jvs.2015.02.061_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12265-009-9149-y","article-title":"Gender dimorphisms in progenitor and stem cell function in cardiovascular disease","volume":"3","author":"Herrmann","year":"2010","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jvs.2015.02.061_bib38","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.2741\/2954","article-title":"Atherosclerosis as a disease of failed endogenous repair","volume":"13","author":"Zenovich","year":"2008","journal-title":"Front Biosci"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521416002226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521416002226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T00:42:47Z","timestamp":1565397767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521416002226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0741521416002226"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2015.02.061","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2015.02.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}